Immune modulatory potentials of antineoplaston A-10 in breast cancer patients
- 11 July 2000
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 157 (1), 57-63
- https://doi.org/10.1016/s0304-3835(00)00472-9
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- In vivoinduction of functional FcγRI (CD64) on neutrophils and modulation of blood cytokine mRNA levels in cancer patients treated with G-CSF (rMetHuG-CSF)British Journal of Haematology, 1998
- Changes in apoptosis of human polymorphonuclear granulocytes with agingMechanisms of Ageing and Development, 1997
- Inhibitory Effect of Antineoplaston A10 and AS2-1 on Human Hepatocellular Carcinoma.The Kurume Medical Journal, 1996
- The Effect of Antineoplaston, a New Antitumor Agent on Malignant Brain Tumors.The Kurume Medical Journal, 1995
- Toxicological Study on Antineoplastons A-10 and AS2-1 in Cancer Patients.The Kurume Medical Journal, 1995
- The respiratory burst of neutrophils, a prognostic parameter in head and neck cancer?Clinical Immunology and Immunopathology, 1992
- The Inhibitory Effect of the Combination of Antineoplaston A‐10 Injection with a Small Dose of cis‐Diamminedichloroplatinum on Cell and Tumor Growth of Human Hepatocellular CarcinomaJapanese Journal of Cancer Research, 1992
- Activation of Epstein–Barr virus latent genes protects human B cells from death by apoptosisNature, 1991
- Effects of granulocytes on human neuroblastoma cells measured by chemiluminescence and chromium‐51 release assayJournal of Bioluminescence and Chemiluminescence, 1989
- Mechanisms of antibody-dependent cellular cytotoxicity: the use of effector cells from chronic granulomatous disease patients as investigative probes.Journal of Clinical Investigation, 1980